Pleural plaques are ubiquitous in asbestos exposed populations, but their pathogenesis remains obscure. Fibre burden studies indicate that plaques appear at fibre levels much below those seen in subjects with asbestosis, but considerably above those found in the general population, and that they appear to be associated with high aspect ratio fibres in the parenchyma. Analysis of parietal pleura and plaques typically reveals short fibres of chrysotile,although one recent study has also found long amphibole fibres in localised areas of the parietal pleura. Plaques are seen in subjects exposed to all types of asbestos, but it is unclear whether chrysotile actually plays a role in their pathogenesis, whereas amphiboles clearly produce plaques. Plaques probably(but not certainly) represent a direct effect of fibres reaching the pleura, but there is no understanding of what factors initiate plaque formation, and why they are completely different in structure and distribution from asbestosinduced diffuse pleural fibrosis.

Keywords:
Asbestos, Pleural plaques, Pleura
This content is only available via PDF.
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.